BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29869797)

  • 1. Ribavirin for treating Crimean Congo haemorrhagic fever.
    Johnson S; Henschke N; Maayan N; Mills I; Buckley BS; Kakourou A; Marshall R
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012713. PubMed ID: 29869797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis.
    Soares-Weiser K; Thomas S; Thomson G; Garner P
    BMC Infect Dis; 2010 Jul; 10():207. PubMed ID: 20626907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis.
    Ascioglu S; Leblebicioglu H; Vahaboglu H; Chan KA
    J Antimicrob Chemother; 2011 Jun; 66(6):1215-22. PubMed ID: 21482564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
    Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mefloquine for preventing malaria during travel to endemic areas.
    Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribavirin is not effective against Crimean-Congo hemorrhagic fever: observations from the Turkish experience.
    Ceylan B; Calıca A; Ak O; Akkoyunlu Y; Turhan V
    Int J Infect Dis; 2013 Oct; 17(10):e799-801. PubMed ID: 23773242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial interventions for preventing and treating depression in dialysis patients.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcoholics Anonymous and other 12-step programs for alcohol use disorder.
    Kelly JF; Humphreys K; Ferri M
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012880. PubMed ID: 32159228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid for drug-resistant pulmonary tuberculosis.
    Singh B; Cocker D; Ryan H; Sloan DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012836. PubMed ID: 30893466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic corticosteroids for the treatment of COVID-19.
    Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis.
    Haraka F; Kakolwa M; Schumacher SG; Nathavitharana RR; Denkinger CM; Gagneux S; Reither K; Ross A
    Cochrane Database Syst Rev; 2021 May; 5(5):CD012972. PubMed ID: 34097769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemether for severe malaria.
    Esu EB; Effa EE; Opie ON; Meremikwu MM
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD010678. PubMed ID: 31210357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the crucial parameters regarding the efficacy of ribavirin therapy in Crimean-Congo haemorrhagic fever (CCHF) patients: a systematic review and meta-analysis.
    Arab-Bafrani Z; Jabbari A; Mostakhdem Hashemi M; Arabzadeh AM; Gilanipour A; Mousavi E
    J Antimicrob Chemother; 2019 Dec; 74(12):3432-3439. PubMed ID: 31369086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutics for treating mpox in humans.
    Fox T; Gould S; Princy N; Rowland T; Lutje V; Kuehn R
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD015769. PubMed ID: 36916727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic therapy for pulmonary embolism.
    Zuo Z; Yue J; Dong BR; Wu T; Liu GJ; Hao Q
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD004437. PubMed ID: 33857326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
    Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
    Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic corticosteroids for paediatric heart surgery with cardiopulmonary bypass.
    Gibbison B; Villalobos Lizardi JC; Avilés Martínez KI; Fudulu DP; Medina Andrade MA; Pérez-Gaxiola G; Schadenberg AW; Stoica SC; Lightman SL; Angelini GD; Reeves BC
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013101. PubMed ID: 33045104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.
    Rivas-Ruiz R; Villasis-Keever M; Miranda-Novales G; Castelán-Martínez OD; Rivas-Contreras S
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009031. PubMed ID: 30887505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.